Addition of CYTOMEL therapy in patients with diabetes mellitus may perhaps worsen glycemic Manage and cause greater antidiabetic agent or insulin specifications. Cautiously check glycemic Management, specially when CYTOMEL is began, modified, or discontinued [see WARNINGS AND Safeguards]. Because of inconsistencies involving the drug labels on DailyMed and also the http://www.t3tiromel.com